Portfolio company
Grail
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops multi-cancer early detection blood tests for asymptomatic adults at elevated risk and healthcare systems to identify cancer signals across many types.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Guardant Health
The company develops blood-based tests to detect and monitor cancer for patients, healthcare providers, and biopharmaceutical researchers.
Freenome
This company develops blood-based screening tests to detect cancer early for patients, healthcare providers, and biopharmaceutical partners.
Guardant
The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.
Thrive Earlier Detection
This digital health company develops a multi-cancer liquid biopsy test to help healthcare providers detect various cancers through early-stage blood screening.
Delfi Diagnostics
This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.
Foundation Medicine
This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
PrognomiQ
This healthcare company develops multi-omics blood tests for the early detection and monitoring of cancer and complex diseases for clinical health systems.
